Last week, a U.S. Circuit Court of Appeals lifted the injunction placed on federal funding for human embryonic stem cell research – but for how long? While Federal funding of research can continue while the case is fully processed, the fight isn’t over and any further delays could prove catastrophic for researchers. Leonard Zon, MD, director of the Stem Cell Program at Children’s Hospital Boston spoke to CNN about the irrevocable damage that even temporary delays can cause to stem cell research.
“With Judge Lamberth’s decision, American scientists have been put at a disadvantage against their counterparts all over the world. The U.S. is in danger of being surpassed as the leader in biomedical research by several countries, including South Korea, Singapore, and Great Britain. The loss of research competitiveness undermines our biotech and pharmaceutical companies’ ability to bring new therapies to patients.”
Read more here.